BT7480 clinical trials

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

This study is testing a new drug, BT7480, alone and with an existing drug, nivolumab, for advanced cancers that have a specific marker called Nectin-4. We want to find the safest dose, understand side effects, and see how well it works.